Display:
15 publications

ESCP Impact Papers

2025

DUCLOUX-BAUDINIÈRE, J., F. JALLAT

The impact of artificial intelligence on the transformation and optimization of drug launches: How executives from the health industry perceive the ongoing revolution

ESCP Impact Papers, 2025-02-EN

ESCP Impact Papers

2025

MACEDO, S., F. JALLAT

Exploring the potential impact of artificial intelligence on the redefinition of the value in health equation

ESCP Impact Papers, 2025-13-EN

ESCP Impact Papers

2025

JALLAT, F., G. MORILLON

The rise of AI in biopharmaceuticals: uncovering the environmental cost and the promise of sustainable AI

ESCP Impact Papers, 2025-44-EN

ESCP Impact Papers

2025

DUCLOUX-BAUDINIÈRE, J., F. JALLAT

De l’impact de l’intelligence artificielle sur la transformation et l’optimisation du lancement des médicaments : Regard porté par les dirigeants des industries de santé sur une révolution en marche

ESCP Impact Papers, 2025-45-FR

ESCP Impact Papers

2024

CORONATI, L., F. JALLAT

Understanding the importance of political risk today: Insights for thriving in a global, unstable, turbulent landscape

ESCP Impact Papers, 2024-30-EN

ESCP Impact Papers

2024

BRUNEL, K., F. JALLAT

Discrimination, inclusion et technologies de santé : La FemTech à l’aune de la donnée et de l’accès à l’innovation

ESCP Impact Papers, 2024-72-FR

Books

2023

JALLAT, F.

Le marketing aujourd’hui

De Boeck

Chapters

2023

JALLAT, F.

Service as a dominant logic and its implication for pricing

In: Encyclopedia of Services, Faïz & Camal Gallouj, Marie-Christine Monnoyer & Luis Rubalcaba Edward Elgar

ESCP Impact Papers

2023

AOUCHICHE, R., F. JALLAT

Innovation thérapeutique et santé numérique - Les promesses de l’Intelligence Artificielle sur l’amélioration du parcours de soins en cancérologie

ESCP Impact Papers, 2023-26-FR

ESCP Impact Papers

2022

JALLAT, F., L. CORONATI

Why are leaders not taking political risks seriously enough despite a turbulent international business environment and geopolitical instability?

ESCP Impact Papers, 2022-09-EN

Academic Director – MSc. in Biopharmaceutical Management (MsM - Paris & London)

Associate Researcher of the New Platform Strategies Chair Sonepar / ESCP Business School

Scientific Director – Doctorate in Business Administration (DBA - UAE)

Scientific Director for Regional seminars in China & SEA – Executive MBA

Deputy Director - Business & Law Division (Athens Institute, ATINER - Greece)

Member - Harvard Business Review Advisory Council

Secretary General - S3Odéon (Sciences, Santé & Société)

Member of the board - Healthcare Data Institute (HDI)

Member of the scientific committee - Boston Biotech Summit

Affiliated Professor - Sciences Po. Paris

Affiliated Professor - French Fashion Institute (IFM)

Looking for someone esle ?
ESCP faculty directory